The past, present, and future of research on neuroinflammation-induced mild cognitive impairment: A bibliometric

Ming Cai1, Yuanqi Zhang2, Si Chen2

  • 1College of Rehabilitation Sciences, Shanghai University of Medicine and Health Sciences, Shanghai, China.

Abstract

Insights

Neuroinflammation is a key factor in mild cognitive impairment (MCI), a precursor to dementia. Research is rapidly growing, focusing on microglia activation and metabolites, with future directions in regulating glial cells for MCI treatment.

Area of Science:

  • Neuroscience
  • Pathology
  • Biomedical Research

Background:

  • Mild cognitive impairment (MCI) is a precursor to dementia.
  • Neuroinflammation is a suspected primary pathogenic mechanism in MCI.
  • Underlying neurobiological mechanisms require further exploration.

Purpose of the Study:

  • To create a visual model map of neuroinflammation-induced MCI research from 2011-2021.
  • To identify research hotspots and predict future trends in the field.
  • To facilitate advancements in MCI research and development.

Main Methods:

  • Searched Web of Science for "neuroinflammation" and "mild cognitive impairment" (2011-2021).
  • Utilized CiteSpace and VOSviewer for visual mapping and collaboration analysis.
  • Analyzed high-frequency keywords and co-cited references for research themes and directions.

Main Results:

  • 226 articles published, with a significant increase since 2018.
  • The United States led in publications and citations; National Institute on Aging was most productive.
  • Current focus on metabolites affecting microglial activation; keywords include "tau," "TREM2," and "mouse model."

Conclusions:

  • Research on neuroinflammation-induced MCI is rapidly expanding.
  • Collaboration between nations and institutions should be enhanced.
  • Future studies should target microglia and astrocyte regulation to treat MCI.

Related Concept Videos